HKSE - Delayed Quote HKD
JACOBIO-B (1167.HK)
3.900
+0.200
+(5.41%)
At close: 4:08:09 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-324,863
-364,199
-292,418
-147,492
78,825
Investing Cash Flow
-174,908
-48,001
-686,322
161,667
-215,564
Financing Cash Flow
82,708
246,278
-9,854
109,057
1,275,381
End Cash Position
366,559
469,155
624,375
1,527,204
1,430,416
Capital Expenditure
-9,474
-38,660
-16,506
-11,135
-10,957
Issuance of Capital Stock
--
139,137
--
132,831
1,103,517
Issuance of Debt
73,477
73,616
--
--
--
Repurchase of Capital Stock
-8,972
-5,682
--
-11,892
--
Free Cash Flow
-334,337
-402,859
-308,924
-158,627
67,868
12/31/2020 - 12/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1875.HK TOT BIOPHARM-B
2.050
+12.64%
9966.HK Alphamab Oncology
6.940
-5.19%
9969.HK InnoCare Pharma Limited
10.520
+1.54%
1952.HK Everest Medicines Limited
46.400
-6.64%
9995.HK RemeGen Co., Ltd.
41.350
+17.14%
1672.HK ASCLETIS-B
6.730
+4.67%
COEP Coeptis Therapeutics Holdings, Inc.
12.47
+9.19%
6160.HK BeiGene, Ltd.
152.200
+0.46%
1801.HK INNOVENT BIO
54.950
+6.80%
6610.TWO TWi Biotechnology, Inc.
11.00
-4.35%